Attenuated Vaccines
Attenuated vaccines use live pathogens engineered or selected to replicate minimally, inducing broad humoral and cellular immunity and often mucosal responses. They can confer rapid, durable protection with dose-sparing potential, but require optimized genetic stability, thermostability, manufacturability, and safety profiling for deployment in military environments.
Technical Challenges
Risk of reversion to virulence or residual pathogenicity in immunocompromised or polytrauma patients
Cold-chain dependence and limited thermostability that constrain austere deployment
Scalable GMP manufacturing and lot-to-lot consistency for complex live biologicals
Regulatory and safety demonstration for genetically modified live organisms in field settings
Emerging Opportunities
Genetic attenuation strategies ensuring irreversible, multi-locus attenuation to prevent reversion
Formulations enabling prolonged ambient stability and simple field reconstitution or needle-free delivery
Validated safety profiles for soldiers with varied immunologic status, including those with trauma or immune-suppressing conditions
Rapid manufacturing platforms and bridging studies tailored to emergent threat pathogens
Current and Emerging Technologies in Attenuated Vaccines
Rational genetic attenuation and synthetic biology
Targeted deletions, codon deoptimization, and multi-gene attenuation reduce reversion risk while preserving immunogenicity; synthetic biology enables rapid design against novel threats.
Thermostable formulations and lyophilization
Lyophilized and excipient-optimized vaccines, sugar-glass matrices, and novel stabilizers reduce cold-chain dependence for forward-deployed units.
Alternative delivery systems
Mucosal (intranasal/aerosol) and microneedle patch platforms enable rapid mass administration, dose-sparing, and improved mucosal immunity relevant to respiratory threats.
Advanced adjuvant and immune-modulatory approaches
Adjuvants and host-directed formulations tailor innate activation to enhance safety and durability while minimizing reactogenicity in stressed warfighter populations.
Modular rapid-manufacturing and quality control
Platform-based GMP workflows, digital in-process controls, and molecular potency assays shorten time-to-clinic for emergent pathogen vaccines.
Importance to Military Medicine
Force readiness and outbreak containment
Rapidly deployable vaccines protect personnel from infectious threats, preserving unit cohesion and mission capability during outbreaks or deployments.
Austere and prolonged-field care suitability
Thermostable, single-dose or mucosal attenuated vaccines reduce logistic burden and enable protection when evacuation or delivery infrastructure is limited.
Compatibility with combat casualty care realities
Safety profiles that account for polytrauma, immunomodulation, and concurrent therapies are essential for vaccinating wounded or medically complex service members.
Surge capacity for biodefense and novel threats
Platform attenuated vaccines support rapid response to emerging biological threats and deliberate attacks with scalable production and pre-existing safety frameworks.
Alignment with the MTEC Mission
Directly advances MTEC’s DoD-focused mission by accelerating development of medical countermeasures that sustain warfighter health and operational readiness.
Aligns with MTEC’s broad portfolio spanning infectious disease, biodefense, and prolonged/distributed care through platform-based vaccine technologies.
Supports rapid transition from research to field-ready solutions via consortium-enabled public–private partnerships, GMP bridging, and DoD-directed studies.
Dual-Use (Military + Civilian) Applications
Dual-use value: attenuated vaccines developed for military threats translate directly to civilian public health needs for pandemic preparedness and endemic disease control.
Technology spillover to civilian markets includes thermostable formulations, needle-free delivery, and rapid manufacturing platforms that benefit hospitals and global health programs.
Regulatory pathways and safety data generated under DoD partnerships accelerate licensure and emergency use authorizations for dual-use applications.
Collaborative clinical trials and field evaluations produce evidence applicable to civilian mass-vaccination, outbreak response, and low-resource settings.
Explore MTEC Members with Attenuated Vaccines Capabilities
MTEC members bring multidisciplinary strengths—academic immunology, industrial-scale GMP manufacturing, synthetic biology, clinical trial networks, and DoD operational medicine—to advance attenuated vaccine candidates from design to deployment.
Members contribute rapid prototyping, thermostability formulation expertise, forward-deployable delivery platforms, and access to military clinical sites for pivotal evaluations.
Explore member profiles to identify partners with GMP capacity, regulatory experience, and operational medical insight to co-develop attenuated vaccine solutions for the Warfighter and civilian populations.
103 Members with Attenuated Vaccines capabilities.
The University of Texas System is a leading public university system in the United States, dedicated to improving lives through education, health care, and research. With over 256,000 students enrolled across 14 institutions, the UT System is committed to providing affordable access to higher education and producing a skilled workforce to drive Texas's economy.
Georgia Southern University is a vibrant institution with over 26,100 students across three campuses in Statesboro, Savannah, and Hinesville. The university offers 132 degree programs at the associate, bachelor’s, master’s, and doctorate levels, emphasizing student success, community impact, and research excellence. With a commitment to inclusivity and engagement, Georgia Southern fosters a supportive environment for diverse learners, including military-affiliated and adult students. The university is dedicated to transforming lives through education and community engagement, aligning its programs with regional needs. Additionally, Georgia Southern provides accelerated pathways for students to fast-track their master's degrees, enhancing educational opportunities. The university also emphasizes career readiness and public impact research, preparing students for successful careers and contributing to community development.
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
The University of Texas at San Antonio (UTSA) is dedicated to the advancement of knowledge through research, teaching, and community engagement. As a premier public research university, UTSA embraces multicultural traditions and serves as a catalyst for socioeconomic development, providing access to educational excellence and preparing citizen leaders for the global environment.
The Precision Vaccines Program (PVP), based in the Department of Pediatrics at Boston Children’s Hospital, is an academic research initiative dedicated to discovering and developing next-generation vaccines tailored to vulnerable populations. PVP conducts both basic and translational research to create novel vaccines and therapeutics for diseases that disproportionately affect infants, older adults, and immunocompromised individuals. The program brings together experts in vaccinology, clinical trials, immunology, molecular biology, data management, biostatistics, bioinformatics, and systems biology, fostering international collaboration among academia, government, and industry to advance precision medicine in vaccinology.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
The Institute for Integrative & Innovative Research (I3R) at the University of Arkansas is dedicated to pioneering solutions to complex societal challenges through convergence research. With a mission to advance research excellence and stimulate economic development, I3R focuses on deploying innovations at scale through collaboration across various sectors, including academia, industry, and government.
UTMB is dedicated to supporting research, education, and scholarly endeavors, with a focus on creating the future of healthcare through innovative research and community engagement.
Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.
The University of Queensland (UQ) is one of Australia's leading research and teaching institutions, dedicated to transforming lives through education and research. UQ aims to create a better future by equipping students with the skills and knowledge necessary for their chosen careers, while also addressing some of the world's most complex challenges through innovative research.
The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.
Boston University is a major research institution committed to leading breakthroughs across various disciplines. The Office of Research supports and advances research excellence, fostering collaboration among researchers, industry partners, and government leaders to address significant societal challenges.
Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.
Founded in 2016, Maxwell Biosciences is a preclinical stage biotechnology company focused on developing innovative therapeutics targeting viruses, bacteria, fungi, and biofilm formations. Utilizing a unique drug-discovery platform, the company aims to create affordable and effective health solutions to combat infectious diseases and enhance healthspan.
The Molinaroli College of Engineering and Computing at the University of South Carolina fosters innovation by preparing engineers and computing professionals to develop new technologies that will improve lives and the world. The college is committed to addressing real-world challenges through education, research, and community engagement.
Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.
Theradaptive
Theradaptive’s RESTORE Trial Initiation for OsteoAdapt™ DE
Theradaptive launches RESTORE Phase I/II trial of OsteoAdapt™ DE for faster, precision bone healing in craniofacial injuries. MTEC-funded study targets improved recovery for military and civilian patients.
Altec
Autonomous Rehabilitation Device for Improved Recovery in Warfighters
The OSCIR platform—developed by Altec Inc in collaboration with the Naval Health Research Center—is bringing clinical-grade, real-time movement analysis to the front lines. Funded under MTEC-22-02-MPAI